Key Trends Influencing the Growth of the Multiomics Market in 2025: Innovative Single-Cell Multiomics Platforms Transforming Research

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Multiomics Market Through 2025?
The size of the multiomics market has seen swift expansion in the past few years. It is projected to rise from $3.27 billion in 2024, hitting $3.85 billion in 2025. This growth signifies a compound annual growth rate (CAGR) of 17.9%. Factors contributing to the unparalleled growth during the historic period include the surge in biomedical research, elevated government and private investment, an upsurge in chronic diseases incidence, advances in technology, and improved computational tools and software for analyzing data.

What's the Projected Size of the Global Multiomics Market by 2029?
Expectations are high for sharp expansion in the multiomics market in the coming years, with projected growth to $7.38 billion in 2029 at a CAGR of 17.6%. Factors contributing to this predicted increase during the forecast period include advancements in machine learning and artificial intelligence, broader clinical application, growth within the biopharmaceutical industry, the emergence of integrated multiomics platforms, and an increase in agricultural and environmental research utilising multiomics. Key trends anticipated in the forecast period encompass technological advancements, commercial launch of new multiomics platforms, utilization of spatially resolved multiomics analysis, application in biopharmaceutical research and development, and widening scope into the field of clinical diagnostics.

View the full report here:
https://www.thebusinessresearchcompany.com/report/multiomics-global-market-report

Top Growth Drivers in the Multiomics Industry: What's Accelerating the Market?
The surge in the requirement for personalized medicine is anticipated to drive the expansion of the multiomics market in the future. Personalized medicine is a medical strategy that tailors healthcare decisions and treatments to suit individual patients, taking into account factors such as their genetics, environment, and lifestyle. This customized approach to medicine is gaining popularity owing to technological progress, the escalating demand for targeted therapies, and overall improvements in global healthcare. Multiomics plays a crucial role in personalized medicine by offering an in-depth comprehension of a patient's genetic, molecular, and metabolism makeup, thereby empowering healthcare professionals to adapt treatments according to each patient's distinctive traits. For instance, the Personalized Medicine Coalition, a non-profit organization in the US, reported in February 2024, that the FDA had sanctioned 16 innovative personalized therapies for patients with rare diseases in 2023, as opposed to just 6 in 2022. Consequently, the burgeoning demand for personalized medicine is fuelling the expansion of the multiomics market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15866&type=smp

What Trends Will Shape the Multiomics Market Through 2029 and Beyond?
Key players in the multiomics market are innovating single-cell multiomics platforms with advanced features. These platforms are designed to allow scientists to conduct extensive studies without compromising the integrity of the sample. Utilizing a combination of various omics and artificial intelligence capabilities, these platforms provide the ability to seamlessly analyze and understand complicated biological data with the assistance of complex algorithms and machine learning techniques. Notably, Becton, Dickinson, and Company-a US-based medical device firm-introduced a high-throughput single-cell multiomics platform, the BD Rhapsody HT Xpress in February 2023. This groundbreaking system is designed for scientists to segregate, barcode, and analyze single cells on a large scale, handling up to eight times more cells than older BD single-cell analysis versions. The system also ensures that no sample is lost during the process and allows for the analysis of various samples and different cell sizes and types at the same time-like stem cells or cancer cells, thus boosting researchers' capacity to garner more insights in a shorter period.

What Are the Main Segments in the Multiomics Market?
The multiomics market covered in this report is segmented -

1) By Type: Single-Cell Multiomics, Bulk Multiomics
2) By Platform: Genomics, Transcriptomics, Proteomics, Metabolomics, Integrated Omics Platforms
3) By Application: Diagnostics, Drug Discovery And Development, Personalized Medicine, AgriGenomics, Other Applications
4) By End User: Academics And Research Organization, Pharmaceutical And Biotechnology Companies, Clinical research Organization, Other End-Users

Subsegments:
1) By Single-Cell Multiomics: Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Epigenomics, Single-Cell Proteomics, Single-Cell Metabolomics
2) By Bulk Multiomics: Genomics, Transcriptomics, Epigenomics, Proteomics, Metabolomics

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=15866&type=smp

Which Top Companies are Driving Growth in the Multiomics Market?
Major companies operating in the multiomics market are Bayer AG, Thermo Fisher Scientific Inc., Novartis AG, Becton Dickinson and Company, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Shimadzu Corporation, Bruker Corporation, Bio-Techne, Azenta Life Sciences, 10x Genomics, Ginkgo Bioworks, Abcam limited, BioLegend, Oxford Nanopore Technologies Plc, Adaptive Biotechnologies, Pacific Biosciences, Standard BioTools, Parse Biosciences, Mission Bio, CD Genomics, Singleron Biotechnologies, Psomagen, BGI Group

Which Regions Will Dominate the Multiomics Market Through 2029?
North America was the largest region in the multiomics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the multiomics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15866

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.